Security key
09627Y109
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC)
CUSIP: 09627Y109
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 65,000,000
- Total 13F shares
- 42,824,142
- Share change
- +4,079,917
- Total reported value
- $3,229,416,996
- Put/Call ratio
- 30%
- Price per share
- $75.41
- Number of holders
- 166
- Value change
- +$311,339,150
- Number of buys
- 110
- Number of sells
- 51
Report period
Q4 2017
Institutions
166
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 09627Y109
Recent filing periods:
Top shareholders of BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q4 2017
As of 31 Dec 2017,
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) was held by
166 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,824,142 shares.
The largest 10 holders included
FMR LLC, Vanguard Group Inc, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, TRV GP II, LLC, LORD, ABBETT & CO. LLC, OppenheimerFunds, Inc., STATE STREET CORP, and Hillhouse Capital Management, Ltd..
This page lists
166
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
134
Q4 2017 holders
166
Holder diff
32
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.